Antiangiogenesis Mediates Cisplatin-Induced Peripheral Neuropathy
Author(s) -
Rudolf Kirchmair,
Dirk Walter,
Masaaki Ii,
Kilian Rittig,
Anne Barbara Tietz,
Toshinori Murayama,
Costanza Emanueli,
Marcy Silver,
Andrea Wecker,
Carole Amant,
Peter Schratzberger,
Youngsup Yoon,
Alberto Weber,
Eleftheria Maria Panagiotou,
Kenneth M. Rosen,
Ferdinand H. Bahlmann,
Lester S. Adelman,
David H. Weinberg,
Allan H. Ropper,
Jeffrey M. Isner,
Douglas W. Losordo
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.470849
Subject(s) - medicine , vascularity , peripheral neuropathy , cisplatin , genetic enhancement , pathology , vascular endothelial growth factor , cancer research , chemotherapy , endocrinology , biology , gene , biochemistry , vegf receptors , diabetes mellitus
Toxic neuropathies induced by cisplatin and other chemotherapeutic agents are important clinical problems because of their high incidence, their lack of effective treatment, and the fact that neuropathy represents a dose-limiting factor for these therapies. The pathogenic basis for toxic neuropathies induced by chemotherapeutic agents has not been completely elucidated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom